Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
REVENUE:        
Product revenue, net $ 2,208 $ 4,690
COSTS AND EXPENSES:        
Cost of revenue 3,367 5,027
Research and development 9,698 21,976 22,561 48,487
Selling, general and administrative 7,502 7,026 16,812 14,417
Asset impairment charges 58,957 58,957
  79,524 29,002 103,357 62,904
Operating loss (77,316) (29,002) (98,667) (62,904)
(Loss) gain on change in fair value of warrant liabilities (855) 6,150
Other (expense) income, net (605) 646 (1,198) 1,543
Net loss available to common stockholders $ (78,776) $ (28,356) $ (93,715) $ (61,361)
Net loss per common share, basic $ (19.28) $ (49.23) $ (27.33) $ (107.45)
Net loss per common share, diluted $ (19.28) $ (49.23) $ (27.33) $ (107.45)
Weighted average common shares outstanding, basic 4,085,132 576,047 3,428,906 571,089
Weighted average common shares outstanding, diluted 4,085,132 576,047 3,428,906 571,089